Current Approaches to Novel Therapeutics in Pancreatic Cancer
Corina E. Akerele(Montefiore Medical Center), Irina Rybalova(Albert Einstein College of Medicine), Howard L. Kaufman(Penn Presbyterian Medical Center), Sridhar Mani(Albert Einstein College of Medicine)
Cited by 8
Abstract
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al.|Journal of Clinical Oncology|1997|5.9k
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with<i>p16</i><sup>INK4</sup>Mutations
Alisa M. Goldstein, Mary C. Fraser, Jeffery P. Struewing et al.|New England Journal of Medicine|1995|616
Cancer Statistics for African Americans
Ateeq Ur Rehman Ghafoor, Ahmedin Jemal, Vilma Cokkinides et al.|CA A Cancer Journal for Clinicians|2002|553